
Inhibiting oxygen sensor leads to a reduced spread of breast cancer throughout the body.

Inhibiting oxygen sensor leads to a reduced spread of breast cancer throughout the body.

Catch up with the latest developments in cancer research.

Weight cycling may influence the biological processes that can lead to cancer.

High cost of research and development causes less investment by pharmaceutical firms.

Researchers predict the progression of the cancer based on its expression of IL13RA2.

Study finds significant barriers to health care access, including stigmatization.

Studies show inexpensive, generic drugs can help reduce breast cancer mortality in postmenopausal women.

Novel oral soluble film is indicated to prevent highly and moderately emetogenic chemotherapy-induced nausea and vomiting.

Amino acid abundant in meat and fish could open receptors in cancer cells.

Particles are surrounded by a protective coating to release drugs in the presence of a specific tumor enzyme.

Silver is a useful element to prevent bacterial growth.

Study finds less than half of cancer patients have a completed will.

Targeting protein that helps cancer cells survive chemotherapy shows promise.

Hormones that reduce side effects may stimulate growth of cells resistant to therapy.

Size and speed of tumor growth similar in dogs and humans.

Increasing immune cell infiltration into tumors induces the immune system to block tumor growth.

Duration of sleep and snoring may play a role in survival outcomes.

Early palliative care reduces costs more than traditional treatment standards.

Glioblastoma treatment with surgical resection may benefit patients with worst prognoses.

Undertreated side effects in treatment of some colon and stomach cancers need to be addressed.

Combination therapy with AKT inhibitors shows promise.

Test projects which agent will work best against particular tumors.

Treatment advances have caused significant progress in survivorship.

Top stories of the week on Specialty Pharmacy Times from May 18 to May 22.

New approach seeks to lessen resistance to cancer drugs while mitigating adverse events.